In our previous works, we demonstrated that human neural stem cells (NSCs) transduced with the cytosine deaminase (CD) gene showed remarkable 'bystander killer effect' on glioma and medulloblastoma cells after administration of the prodrug 5-fluorocytosine (5-FC). In addition, herpes simplex virus thymidine kinase (TK) is a widely studied enzyme used for suicide gene strategies, for which the prodrug is ganciclovir (GCV). To apply this strategy to brain metastasis treatment, we established here a human NSC line (F3.CD-TK) expressing the dual suicide genes CD and TK. We examined whether F3.CD-TK cells intensified the antitumor effect on lung cancer brain metastases. In vitro studies showed that F3.CD-TK cells exerted a marked bystander effect on human lung cancer cells after treatment with 5-FC and GCV. In a novel experimental brain metastases model, intravenously administered F3 cells migrated near lung cancer metastatic lesions, which were induced by the injection of lung cancer cells via the intracarotid artery. More importantly, F3.CD-TK cells in the presence of prodrugs 5-FC and GCV decreased tumor size and considerably prolonged animal survival. The results of the present study indicate that the dual suicide gene-engineered, NSC-based treatment strategy might offer a new promising therapeutic modality for brain metastases.
INTRODUCTION
Brain metastases are the most common cause of intracranial tumor in adults, and up to 45% of cancer patients eventually develop brain metastases during the course of their illness, with 98,000-170,000 new cases diagnosed each year in the United States. A solitary brain metastasis can be managed by local treatment modalities such as surgery and irradiation. However, a number of patients with brain metastasis harbor multiple lesions, so systemic chemotherapy remains the possible treatment option. 1 On the other hand, the intact blood-brain barrier is largely impermeable to most chemotherapeutic drugs. Reaching effective doses of chemotherapeutic agents to the brain may require administration of high doses that could pose a risk of systemic toxicity due to the narrow window between therapeutic and toxic levels. [2] [3] [4] Therefore, development of a new delivery system designed to target brain metastases directly is essential. Previously, we have developed human neural stem cells (NSCs) engineered to express the therapeutic cytosine deaminase (CD) gene that have shown the capacity to migrate selectively to infiltrative glioma and disseminated medulloblastoma, where they significantly reduced the tumor burden after administration of the prodrug 5-fluorocytosine (5-FC). 5, 6 Although the CD-5FC suicide gene system is unique, and tumor-specific gene delivery should limit systemic toxicity, the presence of side effects is still an issue in clinical practice. 7, 8 Another major limitation of the CD-5FC suicide gene system is the inefficient conversion of 5-FC to 5-fluorourasil after transfection. 2, 9 The herpes simplex virus thymidine kinase gene (HSV-TK) is the most widely studied enzyme in suicide gene strategies. The prodrug for HSV-TK is ganciclovir (GCV); GCV is a derivative of acyclovir, which was developed during the 1970s to treat HSV infections. HSV-TK-mediated phosphorylation of GCV into a monophosphate form is the rate-limiting step in the generation of a cytotoxic drug. Normal mammalian guanylate kinase catalyzes the conversion of the monophosphate to diphosphate form, and then to the triphosphate form. 10, 11 In the present study, we first developed a novel, genetically engineered NSC to express the dual suicide genes CD and TK, and the effect of this dual suicide gene on experimental lung cancer brain metastases was examined.
MATERIALS AND METHODS

Cell culture
HB1.F3 (F3) is an immortalized human NSC line derived from human fetal brain at 15 weeks of gestation and immortalized using an amphotropic, replication-incompetent retroviral vector containing v-myc.
12,13 F3.lacZ, F3.CD and F3.CD-TK human NSC lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units ml À 1 penicillin and 100 mg ml À 1 streptomycin. Human lung cancer cell lines NCI-H460 and NCI-H1299 were maintained in DMEM containing 10% fetal bovine serum, 100 units ml À 1 penicillin and 100 mg ml À 1 streptomycin. retroviral pLPCX backbone and the 2.53-kb CD.TK cDNA. Vectors were packaged by cotransfection of pA317 cells with the CD-TK puro plasmid and the MV12 envelope-coding plasmid. The CD-TK puro retroviral supernatant was used for multiple infections of F3 cells. Transduced F3.CD-TK cells were selected with 3 mg ml À 1 puromycin (Invitrogen, Carlsbad, CA) over 4 weeks (Figure 1 ). The purity of transduced cells was 100% after selection.
The green fluorescence protein (GFP)-expressing lentiviral vector, pLenti6.2-GW/EmGFP (Invitrogen), was transfected into HEK293FT packaging cells with Lipofectamine 2000 (Invitrogen), and culture supernatants were used as a source of viral particles. NCI-H460 cells were plated at 5 Â 10 5 per well in a 6-well plate. Viral particles were transduced into the NCI-H460 cells, and GFP-positive cells (NCI-H460-GFP) were sorted after 2 days.
Dil labeling of NSCs
Before systemic administration from the tail vein of mice, F3.CD.TK cells were prelabeled by incubating for 20 min in a culture medium containing cell tracker CM-Dil (Invitrogen). CM-Dil has a maximum fluorescence emission at 570 nm.
In vitro quantitative assay for bystander killing effect ) or GCV (5 mg ml À 1 ) was added to the medium, and the culture was maintained for 3 additional days. The number of viable cells was assessed by the trypan blue method after 3 days and then compared with that of the culture containing NCI H460 or NCI H1299 cells alone. Each experiment was performed in triplicate.
A novel reproducible lung cancer brain metastasis mouse model Nude mice (6-weeks old, approximately 20 g in body weight) and a microsyringe for nanoliter injection (NanoFiIl, World Precision Instruments, Sarasota, FL, USA) were used. The animals used here were handled in accordance with the institution's guidelines for the care and use of laboratory animals, and adequate measures were taken to minimize pain and discomfort to the animals.
The mice were secured on a proper board in the supine position after inhalation of anesthesia with halothane, and the necks were pulled up to expose the field of view. A 1.0-cm longitudinal incision was made in the skin at the center of the neck, and the tissues of the neck were bluntly dissected under a stereoscopic microscope to expose the pulsating right common carotid artery in the triangular area bounded by the windpipe, the right sternocleidomastoid muscle and the right digastric muscle. The fascia around the carotid sheath was removed, and the internal carotid branch was carefully separated from the nearby vagus nerve. Three 6-0 sutures were then placed under the artery at the proximal and distal sections and in the middle point for preparation. After this procedure, the cell suspension that was stored in a sterile tube on ice was extracted with a 100-ml Hamilton syringe (World Precision Instruments, Sarasota, FL, USA). The distal section of the common carotid artery was ligated temporarily with the prepared suture, and the proximal section of the common carotid artery was ligated and occluded. The purpose of temporarily ligating the suture on the distal section of the common carotid artery was to prevent blood from refluxing during the arteriotomy. The right common carotid artery was then carefully cut between the proximal and distal suture positions and a prepared syringe needle was inserted and carefully fixed with the prepared suture. Then, the syringe was connected carefully and tightly with the syringe needle before the distal suture was loosened and then 1 Â 10 6 NCI H460-GFP or NCI-H460 cells in 100 ml of lung cancer cell suspension was slowly injected, taking extra precautions to avoid leakage of the suspension at the puncture site. The cannula was removed before immediate occlusion of the right common carotid artery by distal suture ( Figure 2 ). The postoperative activities of the mice were observed after the skin was sutured. This intracerebral model was reproducible and mice exhibited a survival of 25-35 days.
Confirmation of early-stage metastatic tumors and in vivo affinity of F3 cells to the tumors
To confirm tumor formation at the early stage, the brain was sectioned 1 week after the injection of NCI-H460-GFP cells. The sections were observed under a fluorescence microscope (Olympus, Tokyo, Japan), and were also stained with hematoxylin and eosin.
To show the affinity of the F3 NSCs to brain metastatic tumors, on day 7 after the establishment of the brain metastasis model with the inoculation of NCI H460-GFP cells, the animals (n ¼ 5) were injected intravenously through the tail vein with 1 Â 10 6 Dil-labeled F3 cells diluted in 100 ml of phosphate-buffered saline (PBS). After 7 days, the sections were observed under a confocal microscope (Olympus). The adjacent sections also were processed for hematoxylin and eosin staining.
Treatment of lung cancer brain metastasis mouse model with NSCs expressing CD-TK
The animals were randomly divided into five groups 7 days after the implantation of NCI-H460 lung cancer cells into the right common carotid artery, and five mice were each intravenously injected through the tail vein with PBS, F3.lacZ or F3.CD-TK cells (1 Â 10 6 cells in 100 ml of PBS). After an additional 2 days, PBS, 5-FC alone or 5-FC (500 mg kg À 1 ) combined with GCV (25 mg kg À 1 ) was injected intraperitoneally to the five groups of mice ) was calculated by summation of the cross-sectional areas. In addition, the antitumor effect of the F3.CD-TK NSCs with the prodrugs was evaluated by measuring the overall survival of the mice.
Statistical analyses
The statistical significance of the observed differences was determined by analysis of variance (StatView software, SAS Institute, Cary, NC, USA), and subsequently, Bonferroni's correction for multiple comparisons was applied. Survival curves were generated using the Kaplan-Meier method. The log-rank statistic (StatView) was used to compare the distribution of the survival times. All reported P-values were two-sided; a P-value o0.05 was considered statistically significant.
RESULTS
Generation of human NSCs expressing both CD and TK
The generated F3.CD-TK cells and the parental F3 cells were treated with either GCV (Figure 3a) or 5-FC (Figure 3b ). Cell viability was assessed at 24 h, and F3.CD-TK became susceptible to both GCV and 5-FC as the concentration of the prodrugs increased. Thus, the result demonstrated that the CD and TK genes introduced with F3.CD-TK cells functioned effectively.
NSCs expressing dual suicide genes exhibit a higher bystander killing effect in vitro Treatment with GCV at a dose of 5 mg ml À 1 and 5-FC at 500 mg ml
resulted in the killing of all F3.CD-TK cells, whereas 100% of lung cancer cells survived, indicating that these were the optimal GCV and 5-FC concentrations for the evaluation of the bystander effect of F3.CD-TK cells in lung cancer brain metastasis (Figure 3c ).
To evaluate the bystander effect, F3.CD-TK and lung cancer cells were co-cultured at various ratios and subsequently treated with 5-FC or a combination of 5-FC and GCV. In the NCI-H460 lung cancer cell line, the number of viable cells was significantly lower after treatment with the combination of 5-FC and GCV compared with cells treated with 5-FC alone (Po0.05) at a high cancer cell/ F3.CD-TK ratio of 20. In addition, the number of viable cells decreased as the ratio decreased (Figure 4a ). The NCI-H1299 lung cancer cell line exhibited similar results: at a cancer cell/F3.CD-TK ratio of 20, the number of viable cells was significantly lower after treatment with the combination of 5-FC and GCV compared with 5-FC alone (Po0.05, Figure 4b ). These results suggest that NSCs expressing the dual suicide genes exerted a more effective bystander effect following 5-FC and GCV treatment compared with 5-FC alone in vitro.
Natural course of a novel brain metastasis mouse model After intra-arterial inoculation of the NCI-H460 lung cancer cells, all mice exhibited severe neurological symptoms, and died within 35 days after surgery (Figure 5a ). After the separate group of mice injected with either NCI-H460 and NCI-H460-GFP were killed, brain sections were prepared for hematoxylin and eosin staining. The invasion of small, round tumor cells derived from the arteries was observed (Figure 5b) .
Multiple metastatic tumors were observed both in the hematoxylin and eosin staining and in the fluorescence microscopic evaluation before treatment (Figure 5c ). F3 cells injected from the tail vein have an affinity to brain metastatic tumors CM-DiI-labeled F3.CD-TK cells were injected from the tail vein 1 week after the intra-arterial inoculation of GFP-expressing NCI-H460 lung cancer cells. The merged picture shows that Figure 2 . (a) A 1.0-cm longitudinal incision was made in the skin at the center of the neck, and the tissues of the neck were bluntly dissected under a stereoscopic microscope to expose the pulsating right common carotid artery in the triangular area bounded by the windpipe, the right sternocleidomastoid muscle, and the right digastric muscle. (b) The fascia around the carotid sheath was removed, and the internal carotid branch was carefully separated from the nearby vagus nerve. Three 6-0 sutures were then placed under the artery at the proximal and distal sections and in the middle point for preparation. (c) After this procedure, the cell suspension stored in a sterile tube on ice was extracted with a 100-ml syringe, the syringe needle was connected tightly, and air bubbles were removed before injection. The contents of the cell suspension were thoroughly mixed by repeated pipetting before drawing cells into the syringe. The distal section of the common carotid artery was ligated temporarily with the prepared suture, and the proximal section of the common carotid artery was ligated and occluded. The purpose of temporarily ligating the suture on the distal section of the common carotid artery was to prevent blood from refluxing during the arteriotomy. The right common carotid artery was then carefully cut between the proximal and distal suture positions, and a prepared syringe needle was inserted and carefully fixed with the prepared suture. did not show significant tumor growth inhibition. By contrast, the tumor volume was significantly inhibited in group 4. Furthermore, mice treated with F3.CD.TK cells followed by the combination of 5-FC and GCV (group 5) shows significantly stronger tumor growth inhibition than that treated with F3.CD.TK cells followed by 5-FC alone (group 4, 7.85±1.26 mm 3 ; group 5, 3.925±1.16 mm 3 ; Po0.05; Figure 6b ). Consistent with the result of measurement of the tumor volume, mice treated with F3.CD-TK followed by 5-FC (group 4) demonstrated a statistically significant increase in survival compared with mice treated with PBS (group 1), F3.lacZ cells (group 2) and F3.LacZ followed by the combination of 5-FC and GCV (group 3). Notably, all mice treated with F3.CD-TK followed by the combination of 5-FC and GCV (group 5) survived for a significantly longer period (Po0.05; Figure 6c ). These results indicate that treatment with NSCs expressing the dual suicide genes followed by treatment with a combination of two prodrugs provides a better treatment efficacy owing to transgene expression and the subsequent bystander effect. The discovery of the tumor-tropic migrating capability of NSCs opens a new chapter for gene therapy. The ability of NSCs to migrate selectively into primary brain tumors such as gliomas and medulloblastomas has been reported in recent studies. [18] [19] [20] [21] [22] However, to our knowledge, this is the first report showing that NSCs can target metastatic brain tumors resulting from clinically relevant transarterial metastasis. A recent research has reported that NSCs injected into the ipsilateral hemisphere migrated into breast tumor metastases in the contralateral hemisphere. 23 Our recent study demonstrated that intravenously administered F3 human NSCs expressing either a carboxylesterase suicide enzyme or the immune moderator interferon-b gene selectively targeted and migrated to glioblastoma, 7 completely relieving the tumor burden. In the present study, F3.CD-TK cells injected into the tail vein migrated into experimentally generated lung cancer brain metastasis. We further suggests that lung cancer brain metastases attract NSCs in a manner similar to that of primary brain tumors, thus demonstrating that NSCs have selective tumor-tropic ability and can be used as therapeutic vehicles for gene delivery to brain metastases. 24 We inoculated NSCs by tail vein injection instead of intracranial injection. As the tumortropic ability of NSCs had been demonstrated previously, this intravenous track should be more feasible for application in a clinical setting. Although lung cancer is the most common source of brain metastasis, relatively little progress has been made in the development of an experimental model of brain metastasis from lung cancer. 25 We established a new experimental model of brain metastasis from lung cancer by injecting lung cancer cells into the right internal carotid artery. Treatment with F3.CD-TK NSCs demonstrated significant therapeutic benefits in animal models of lung cancer brain metastasis. The present report is of a novel brain metastasis model that can mimic the migration of lung cancer cells through the blood.
In summary, our results demonstrate that the F3.CD-TK cellbased dual suicide gene delivery system is a potential therapeutic approach for the treatment of brain metastases. 26 Moreover, the use of F3.CD cells was approved by the US FDA for treatment of glioblastoma patients and is currently ongoing at the City of Hope National Medical Center in the USA. This approach could be valuable in the clinical setting as adjuvant therapy for solid tumor brain metastasis. 18 
